Organization type


  • Academic research institution

Early phases


  • Target identification – new biological hypothesis
  • Target validation – Hypothesis verification

Screening


  • Assay development
    • In vivo screening models
  • Screening and high throughput screening using small molecules (including natural product, DNA encoded libraries and fragment libraries)

Optimization phases


  • In vivo animal models (including assay/model development and testing)
  • Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)
    • Safety
    • Toxicology

Functional areas


  • Molecular and cellular biology
    • Gene editing
    • Imaging / High content screening
    • qPCR

Terapeutic areas


  • Cancer
  • Cardiovascular
  • Dermatology
  • Infectious diseases
  • Metabolism / Endocrinology
  • Nervous Central System
  • Rare diseases